Competitive analysis in Genetic Engineering industry

Latest patents granted in the Genetic Engineering industry

Patent:
Grant Date:
Sep 25, 2024
Title:
Central Memory T Cells For Adoptive T Cell Therapy
Applicant:
Patent:
Grant Date:
Sep 18, 2024
Title:
Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin Reinduction
Patent:
Grant Date:
Sep 11, 2024
Title:
Method For Purification Of Retinal Pigment Epithelial Cells
Applicant:
Patent:
Grant Date:
Sep 4, 2024
Title:
Engineered Nucleic Acids And Methods Of Use Thereof
Applicant:
Patent:
Grant Date:
Aug 21, 2024
Title:
Culture Medium Containing Uridine And N-Acetyl-D-Mannosamine
Patent:
Grant Date:
Aug 14, 2024
Title:
Disease Resistant Plants
Patent:
Grant Date:
Jun 26, 2024
Title:
Rhizomania-Resistant Gene
Applicant:
Patent:
Grant Date:
Jun 19, 2024
Title:
Multiple Antigen Binding Molecular Fusion, Pharmaceutical Composition, Method For Identifying Linear Epitope, And Method For Preparing Multiple Antigen Binding Molecular Fusion
Patent:
Grant Date:
Jun 19, 2024
Title:
Animal Models And Therapeutic Molecules
Applicant:
Patent:
Grant Date:
Jun 12, 2024
Title:
Liver-Specific Nucleic Acid Regulatory Elements And Methods And Use Thereof

Top patents facing oppositions in Genetic Engineering industry

Patent:
Grant Date:
May 10, 2017
Title:
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
Oppositions:
84
Patent:
Grant Date:
Mar 2, 2022
Title:
Modified Nucleoside, Nucleotide, And Nucleic Acid Compositions
Oppositions:
80
Patent:
Grant Date:
Oct 28, 2020
Title:
Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation
Oppositions:
50
Patent:
Grant Date:
Feb 12, 2020
Title:
Novel Crispr Enzymes And Systems
Oppositions:
48
Patent:
Grant Date:
Feb 28, 2018
Title:
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
Oppositions:
48
Patent:
Grant Date:
May 27, 2020
Title:
Novel Crispr Enzymes And Systems
Oppositions:
48
Patent:
Grant Date:
Apr 3, 2019
Title:
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription
Oppositions:
48
Patent:
Grant Date:
Feb 12, 2020
Title:
Novel Crispr Enzymes And Systems
Oppositions:
48
Patent:
Grant Date:
Aug 22, 2018
Title:
Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof
Oppositions:
36
Patent:
Grant Date:
Sep 18, 2019
Title:
Inducible Dna Binding Proteins And Genome Perturbation Tools And Applications Thereof
Oppositions:
36

Top companies filing oppositions in Genetic Engineering industry

Total oppositions filed:
81
Total oppositions filed:
70
Total oppositions filed:
50
Total oppositions filed:
49
Total oppositions filed:
37
Total oppositions filed:
35
Total oppositions filed:
31
Total oppositions filed:
27
Company:
Total oppositions filed:
26
Company:
Total oppositions filed:
25

Top companies facing oppositions in Genetic Engineering industry

Total facing oppositions:
126
Total facing oppositions:
122
Total facing oppositions:
122
Total facing oppositions:
96
Total facing oppositions:
81
Total facing oppositions:
73
Total facing oppositions:
72
Total facing oppositions:
72
Total facing oppositions:
72
Total facing oppositions:
61

Need more information?

Feel free to send us a message here and we will get back to you